Zhao, E., Bomback, M., Khan, A., Krishna Murthy, S., Solowiejczyk, D., Vora, N. L., Gilmore, K. L., Giordano, J. L., Wapner, R. J., Sanna‐Cherchi, S., Lyford, A., Jelin, A. C., Gharavi, A. G., & Hays, T. (2024). The expanded spectrum of human disease associated with GREB1L likely includes complex congenital heart disease. Prenatal Diagnosis, 44(3), 343–351. Portico. https://doi.org/10.1002/pd.6527

Riedhammer, K. M., Nguyen, T.-M. T., Koşukcu, C., Calzada-Wack, J., Li, Y., Assia Batzir, N., Saygılı, S., Wimmers, V., Kim, G.-J., Chrysanthou, M., Bakey, Z., Sofrin-Drucker, E., Kraiger, M., Sanz-Moreno, A., Amarie, O. V., Rathkolb, B., Klein-Rodewald, T., Garrett, L., Hölter, S. M., … Hoefele, J. (2024). Implication of transcription factor FOXD2 dysfunction in syndromic congenital anomalies of the kidney and urinary tract (CAKUT). Kidney International, 105(4), 844–864. https://doi.org/10.1016/j.kint.2023.11.032

Martino, J., Liu, Q., Vukojevic, K., Ke, J., Lim, T. Y., Khan, A., Gupta, Y., Perez, A., Yan, Z., Milo Rasouly, H., Vena, N., Lippa, N., Giordano, J. L., Saraga, M., Saraga-Babic, M., Westland, R., Bodria, M., Piaggio, G., Bendapudi, P. K., … Sanna-Cherchi, S. (2023). Mouse and human studies support DSTYK loss of function as a low-penetrance and variable expressivity risk factor for congenital urinary tract anomalies. Genetics in Medicine, 25(12), 100983. https://doi.org/10.1016/j.gim.2023.100983

Leow, E. H., Lee, J. H., Hornik, C. P., Ng, Y. H., Hays, T., Clark, R. H., Tolia, V. N., & Greenberg, R. G. (2022). Congenital anomalies of the kidney and urinary tract (CAKUT) in critically ill infants: a multicenter cohort study. Pediatric Nephrology, 38(1), 161–172. https://doi.org/10.1007/s00467-022-05542-0